Literature DB >> 15769904

Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling.

Göran Karlsson1, Yingchun Liu, Jonas Larsson, Marie-José Goumans, Ju-Seog Lee, Snorri S Thorgeirsson, Markus Ringnér, Stefan Karlsson.   

Abstract

Transforming growth factor-beta1 (TGF-beta) regulates cellular functions like proliferation, differentiation, and apoptosis. On the cell surface, TGF-beta binds to receptor complexes consisting of TGF-beta receptor type II (TbetaRII) and activin-like kinase receptor-5 (Alk5), and the downstream signaling is transduced by Smad and MAPK proteins. Recent data have shown that alternative receptor combinations aside from the classical pairing of TbetaRII/Alk5 can be relevant for TGF-beta signaling. We have screened for alternative receptors for TGF-beta and also for gene targets of TGF-beta signaling, by performing functional assays and microarray analysis in murine embryonic fibroblast (MEF) cell lines lacking Alk5. Data from TGF-beta-stimulated Alk5(-/-) cells show them to be completely unaffected by TGF-beta. Additionally, 465 downstream targets of Alk5 signaling were identified when comparing Alk5(-/-) or TGF-beta-stimulated Alk5(+/+) MEFs with unstimulated Alk5(+/+) cells. Our results demonstrate that, in MEFs, TGF-beta signals exclusively through complexes involving Alk5, and give insight to its downstream effector genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15769904     DOI: 10.1152/physiolgenomics.00303.2004

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  12 in total

Review 1.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

2.  Mechanistic exploration of phthalimide neovascular factor 1 using network analysis tools.

Authors:  Kristen A Wieghaus; Erwin P Gianchandani; Milton L Brown; Jason A Papin; Edward A Botchwey
Journal:  Tissue Eng       Date:  2007-10

Review 3.  Smad3 signaling involved in pulmonary fibrosis and emphysema.

Authors:  Jack Gauldie; Martin Kolb; Kjetil Ask; Gail Martin; Philippe Bonniaud; David Warburton
Journal:  Proc Am Thorac Soc       Date:  2006-11

4.  Inner nuclear membrane protein TMEM201 promotes breast cancer metastasis by positive regulating TGFβ signaling.

Authors:  Ya Kong; Yutian Zhang; Hanlin Wang; Weijuan Kan; Haoran Guo; Yun Liu; Yi Zang; Jia Li
Journal:  Oncogene       Date:  2021-11-19       Impact factor: 9.867

Review 5.  Decoding the quantitative nature of TGF-beta/Smad signaling.

Authors:  David C Clarke; Xuedong Liu
Journal:  Trends Cell Biol       Date:  2008-08-15       Impact factor: 20.808

6.  Natural velvet antler polypeptide conformation prediction and molecular docking study with TGF-β1 complex.

Authors:  Yu-Dong Shang; Ji-Long Zhang; Qing-Chuan Zheng
Journal:  J Mol Model       Date:  2013-06-15       Impact factor: 1.810

7.  Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells.

Authors:  Esther S Shao; Laura Lin; Yucheng Yao; Kristina I Boström
Journal:  Blood       Date:  2009-06-08       Impact factor: 22.113

8.  TGF-beta1 reduces the heterogeneity of astrocytic cyclooxygenase-2 and nitric oxide synthase-2 gene expression in a stimulus-independent manner.

Authors:  Mary E Hamby; James A Hewett; Sandra J Hewett
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-12-08       Impact factor: 3.072

9.  Revealing signaling pathway deregulation by using gene expression signatures and regulatory motif analysis.

Authors:  Yingchun Liu; Markus Ringnér
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

10.  TGFβ-mediated suppression of CD248 in non-cancer cells via canonical Smad-dependent signaling pathways is uncoupled in cancer cells.

Authors:  Sahana Suresh Babu; Yanet Valdez; Andrea Xu; Alice M O'Byrne; Fernando Calvo; Victor Lei; Edward M Conway
Journal:  BMC Cancer       Date:  2014-02-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.